"Duke Women's Cancer Care Raleigh provides comprehensive care for women's cancers, including breast cancer and gynecologic cancers. Our team includes specialists in breast cancer surgery, minimally invasive gynecologic surgery, medical oncology, radiology and radiation therapy. In addition, plastic surgery services are available for any related reconstructive or aesthetic procedures you may need."

During the past decade, Duke Women's Cancer Care Raleigh conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke Women's Cancer Care Raleigh" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "CanariaBio Inc." with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Women's Cancer Care Raleigh" #1 collaborator was "NRG Oncology" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Duke Women's Cancer Care Raleigh" are "Ovarian Serous Adenocarcinoma" (2 trials), "Adult Giant Cell Glioblastoma" (1 trials), "Adult Glioblastoma" (1 trials), "Adult Gliosarcoma" (1 trials) and "Advanced Lung Non-Small Cell Carcinoma" (1 trials). Many other conditions were trialed in "Duke Women's Cancer Care Raleigh" in a lesser frequency.

Most popular intervention types in "Duke Women's Cancer Care Raleigh" are "Drug" (9 trials), "Other" (6 trials), "Biological" (5 trials), "Radiation" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (4 trials), "3-Dimensional Conformal Radiation Therapy" (3 trials), "Paclitaxel" (3 trials), "Placebo" (3 trials) and "Questionnaire Administration" (3 trials). Other intervention names were less common.

The vast majority of trials in "Duke Women's Cancer Care Raleigh" are 6 trials for "Female" genders, 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Duke Women's Cancer Care Raleigh". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke Women's Cancer Care Raleigh, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke Women's Cancer Care Raleigh, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".